The Reveal LINQ monitor developed by Medtronic identifies more people who have atrial fibrillation after a cryptogenic stroke (CS) – with no identified cause – or transient ischaemic attack (TIA).

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Last year, for example, a review of more than 3,500 alerts in 61 patients with implanted heart monitors over the course of several months found high rates of false alerts with the devices ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...

Intraoperative NIM nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT ...

The US Food and Drug Administration (FDA) has issued a Class I recall for Medtronic’s NIM Vital Nerve Monitoring System due ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

confirmation and additional details will be provided closer to the specific event. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's ...